Granisetron HCL 1 mg/mL Intravenous Injection, 1 mL Single-Dose Vial

Granisetron Hydrochloride — 1ML, Solution for injection, carton of 1 × 1 mL vial

Granisetron Hydrochloride is a solution for injection for intravenous use. Granisetron hydrochloride injection is a serotonin-3 (5-HT 3 ) receptor antagonist indicated for: • The prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. • The prevention and treatment of postoperative nausea and vomiting in adults. As with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively.

• Active ingredient or product type: GRANISETRON HYDROCHLORIDE
• Strength/concentration: 1ML
• Dosage form and route: Solution for injection, Intravenous
• Exact package presentation: carton of 1 × 1 mL vial
• NDC/item number: 67457-863-01
• Manufacturer: MYLAN INSTITUTIONAL
• Storage/handling: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.] Discard unused portion for the single-dose vials. Discard Unused Portion 30 days after vial penetration Do not freeze. Protect from light.
• Status: Rx only

Important safety information: • Granisetron hydrochloride does not stimulate gastric or intestinal peristalsis and should not be used instead of nasogastric suction. ( 5.1 ) • QT prolongation has been reported with granisetron hydrochloride.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.